• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 CRISPR 系统使磷霉素耐药恢复敏感。

Resensitization of Fosfomycin-Resistant Using the CRISPR System.

机构信息

Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Fiocruz, Curitiba 81350-010, PR, Brazil.

Laboratory of Cell Biology, Carlos Chagas Institute, Fiocruz, Curitiba 81350-010, PR, Brazil.

出版信息

Int J Mol Sci. 2022 Aug 16;23(16):9175. doi: 10.3390/ijms23169175.

DOI:10.3390/ijms23169175
PMID:36012441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9409345/
Abstract

Antimicrobial resistance is a public health burden with worldwide impacts and was recently identified as one of the major causes of death in 2019. Fosfomycin is an antibiotic commonly used to treat urinary tract infections, and resistance to it in Enterobacteriaceae is mainly due to the metalloenzyme FosA3 encoded by the fosA3 gene. In this work, we adapted a CRISPR-Cas9 system named pRE-FOSA3 to restore the sensitivity of a fosA3+ Escherichia coli strain. The fosA3+ E. coli strain was generated by transforming synthetic fosA3 into a nonpathogenic E. coli TOP10. To mediate the fosA3 disruption, two guide RNAs (gRNAs) were selected that used conserved regions within the fosA3 sequence of more than 700 fosA3+ E. coli isolates, and the resensitization plasmid pRE-FOSA3 was assembled by cloning the gRNA into pCas9. gRNA_195 exhibited 100% efficiency in resensitizing the bacteria to fosfomycin. Additionally, the edited strain lost the ampicillin resistance encoded in the same plasmid containing the synthetic fosA3 gene, despite not being the CRISPR-Cas9 target, indicating plasmid clearance. The in vitro analysis presented here points to a path that can be explored to assist the development of effective alternative methods of treatment against fosA3+ bacteria.

摘要

抗微生物药物耐药性是一种具有全球影响的公共卫生负担,最近被确定为 2019 年主要死亡原因之一。磷霉素是一种常用于治疗尿路感染的抗生素,肠杆菌科对其的耐药性主要是由于fosA3 基因编码的金属酶 FosA3 所致。在这项工作中,我们改造了一种名为 pRE-FOSA3 的 CRISPR-Cas9 系统,以恢复 fosA3+大肠杆菌菌株的敏感性。fosA3+大肠杆菌菌株是通过将合成的 fosA3 转化为非致病性大肠杆菌 TOP10 而产生的。为了介导 fosA3 的破坏,选择了两个 gRNA(guide RNA),它们使用了超过 700 个 fosA3+大肠杆菌分离株中 fosA3 序列的保守区域,并且 resensitization 质粒 pRE-FOSA3 通过将 gRNA 克隆到 pCas9 中进行组装。gRNA_195 在使细菌对磷霉素重新敏感方面的效率达到了 100%。此外,尽管编辑菌株不包含 CRISPR-Cas9 的靶标,但仍失去了同一质粒中编码的氨苄青霉素抗性,这表明质粒已被清除。这里呈现的体外分析指出了一条可以探索的途径,以协助开发针对 fosA3+细菌的有效替代治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3c7/9409345/3061788fe6c4/ijms-23-09175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3c7/9409345/ff9f4c821b2a/ijms-23-09175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3c7/9409345/4686ffed8a14/ijms-23-09175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3c7/9409345/d65fd3dea83b/ijms-23-09175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3c7/9409345/3061788fe6c4/ijms-23-09175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3c7/9409345/ff9f4c821b2a/ijms-23-09175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3c7/9409345/4686ffed8a14/ijms-23-09175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3c7/9409345/d65fd3dea83b/ijms-23-09175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3c7/9409345/3061788fe6c4/ijms-23-09175-g004.jpg

相似文献

1
Resensitization of Fosfomycin-Resistant Using the CRISPR System.利用 CRISPR 系统使磷霉素耐药恢复敏感。
Int J Mol Sci. 2022 Aug 16;23(16):9175. doi: 10.3390/ijms23169175.
2
Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.中国温州尿路感染中产超广谱β-内酰胺酶大肠埃希菌的药敏情况及耐药机制研究
Int J Antimicrob Agents. 2017 Jul;50(1):29-34. doi: 10.1016/j.ijantimicag.2017.02.010. Epub 2017 Apr 26.
3
Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.韩国产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌临床分离株中获得性磷霉素耐药的流行情况和 IS26 复合转座子周围的 fosA3。
J Antimicrob Chemother. 2012 Dec;67(12):2843-7. doi: 10.1093/jac/dks319. Epub 2012 Aug 14.
4
Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrug-resistant Escherichia coli from livestock and other animals.质粒介导的磷霉素耐药基因 fosA3 在来自家畜和其他动物的多药耐药大肠杆菌中的传播。
J Appl Microbiol. 2013 Mar;114(3):695-702. doi: 10.1111/jam.12099. Epub 2012 Dec 27.
5
Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan.台湾地区人和猪源耐磷霉素产超广谱β-内酰胺酶大肠杆菌分离株的特性分析
PLoS One. 2015 Aug 17;10(8):e0135864. doi: 10.1371/journal.pone.0135864. eCollection 2015.
6
First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan.日本健康个体中产 CTX-M 型大肠埃希菌中福沙霉素耐药基因 fosA3 的首次检出。
Microb Drug Resist. 2013 Dec;19(6):477-82. doi: 10.1089/mdr.2013.0061. Epub 2013 Aug 3.
7
Hybrid IncFIA/FIB/FIC(FII) plasmid co-carrying bla and fosA3 from an Escherichia coli ST117 strain of retail chicken.一株零售鸡肉源大肠杆菌 ST117 携带 bla 和 fosA3 的 IncFIA/FIB/FIC(FII) 型混合质粒。
Int J Food Microbiol. 2022 Dec 2;382:109914. doi: 10.1016/j.ijfoodmicro.2022.109914. Epub 2022 Sep 6.
8
High prevalence of fosfomycin resistance gene fosA3 in bla CTX-M-harbouring Escherichia coli from urine in a Chinese tertiary hospital during 2010-2014.2010 - 2014年期间,中国一家三级医院尿液中携带bla CTX - M的大肠杆菌对磷霉素耐药基因fosA3的高流行率。
Epidemiol Infect. 2017 Mar;145(4):818-824. doi: 10.1017/S0950268816002879. Epub 2016 Dec 12.
9
Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China.中国产肺炎克雷伯菌碳青霉烯酶肺炎克雷伯菌分离株中质粒介导磷霉素耐药基因决定子的分子流行病学
Microb Drug Resist. 2019 Mar;25(2):251-257. doi: 10.1089/mdr.2018.0137. Epub 2018 Aug 16.
10
Spread and Molecular Characteristics of Carrying -Like Genes from Farms in China.中国养殖场携带样基因的传播和分子特征。
Microbiol Spectr. 2022 Aug 31;10(4):e0054522. doi: 10.1128/spectrum.00545-22. Epub 2022 Jul 19.

引用本文的文献

1
Reinvigorating AMR resilience: leveraging CRISPR-Cas technology potentials to combat the 2024 WHO bacterial priority pathogens for enhanced global health security-a systematic review.重振抗菌药物耐药性的恢复力:利用CRISPR-Cas技术潜力对抗2024年世界卫生组织细菌重点病原体以加强全球卫生安全——一项系统综述
Trop Med Health. 2025 Apr 2;53(1):43. doi: 10.1186/s41182-025-00728-2.
2
Engineering probiotic Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system.利用 I 型 CRISPR-Cas 系统工程改造益生菌 Nissle 1917 以阻断多种抗生素耐药基因的转移。
Appl Environ Microbiol. 2024 Oct 23;90(10):e0081124. doi: 10.1128/aem.00811-24. Epub 2024 Sep 10.
3

本文引用的文献

1
Molecular Epidemiology of Fosfomycin Resistant from a Pigeon Farm in China.中国某鸽场磷霉素耐药性的分子流行病学
Antibiotics (Basel). 2021 Jun 25;10(7):777. doi: 10.3390/antibiotics10070777.
2
Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?新冠疫情期间出现的抗菌药物耐药性威胁:我们处于何种境地?
J Infect Public Health. 2021 May;14(5):555-560. doi: 10.1016/j.jiph.2021.02.011. Epub 2021 Mar 5.
3
Characteristics of fosA-carrying plasmids in E. coli and Klebsiella spp. isolates originating from food and environmental samples.
CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.
CRISPR-Cas 系统:对抗抗生素耐药性的新曙光。
BioDrugs. 2024 May;38(3):387-404. doi: 10.1007/s40259-024-00656-3. Epub 2024 Apr 11.
食品和环境样本中分离的携带 fosA 基因的大肠杆菌和克雷伯菌属质粒的特征。
J Antimicrob Chemother. 2021 Jul 15;76(8):2004-2011. doi: 10.1093/jac/dkab119.
4
Emergence of and in Multidrug-Resistant Isolates From Flowers and the Retail Environment in China.中国花卉及零售环境中多重耐药菌分离株中[具体细菌名称]和[具体细菌名称]的出现 。(你原文中“Emergence of and ”这里有缺失信息)
Front Microbiol. 2021 Feb 5;12:586504. doi: 10.3389/fmicb.2021.586504. eCollection 2021.
5
Detection of ESBL/AmpC-Producing and Fosfomycin-Resistant From Different Sources in Poultry Production in Southern Brazil.巴西南部家禽生产中不同来源产超广谱β-内酰胺酶/头孢菌素酶及耐磷霉素菌株的检测
Front Microbiol. 2021 Jan 11;11:604544. doi: 10.3389/fmicb.2020.604544. eCollection 2020.
6
Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom.评估新冠疫情对英国抗菌药物管理活动/项目的影响。
Antibiotics (Basel). 2021 Jan 23;10(2):110. doi: 10.3390/antibiotics10020110.
7
The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations.新冠疫情期间持续开展抗菌药物管理的必要性及可行建议
Antibiotics (Basel). 2020 Dec 14;9(12):904. doi: 10.3390/antibiotics9120904.
8
Mobile fosfomycin resistance genes in Enterobacteriaceae-An increasing threat.肠杆菌科中的移动磷霉素耐药基因——日益严重的威胁。
Microbiologyopen. 2020 Dec;9(12):e1135. doi: 10.1002/mbo3.1135. Epub 2020 Oct 30.
9
Multiple Plasmid Vectors Mediate the Spread of in Extended-Spectrum-β-Lactamase-Producing Isolates from Retail Vegetables in China.多种质粒载体介导的广泛耐药肠杆菌科细菌在中国零售蔬菜中产超广谱β-内酰胺酶分离株中的传播。
mSphere. 2020 Jul 15;5(4):e00507-20. doi: 10.1128/mSphere.00507-20.
10
CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant .CRISPR-Cas9 介导的碳青霉烯酶基因和质粒在碳青霉烯类耐药菌中的消除。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00843-20.